Xcelens

What Xcelens does

Xcelens International Sagl is a Swiss medical device and dermo-cosmetic company that designs, manufactures, and markets injectable hyaluronic-acid-based aesthetic products. Founded in 2004 in Geneva and originally specialised in ophthalmology, the company has evolved into a full-spectrum aesthetic medicine provider, now headquartered in Mezzovico-Vira, Switzerland, with a marketing and export office in Milan, Italy. Its commercial portfolio spans four categories: dermal fillers (Genyal Polyvalent, Genyal Volumae, the lidocaine-containing Xcelens Extra 3 / Extra 4 / Extreme HV line, and Genyal 200 body filler), skin boosters (Molecholin, Genyal Genyalift, Doublyx Evo), cosmetic cocktails (Peptidyal 86HX, Peptidyal 115, Peptidyak C10, Anti-Yal 1500 hyaluronidase), and dermo-cosmetics (Boosterina PDRN serum and cream, UltraHA face and eye, Shine C). Core manufacturing IP is a proprietary, multi-stage purification and homogenisation process applied to bio-fermented, non-animal hyaluronic acid, producing endotoxin levels below 0.05 EU/g and protein residues described as among the lowest in the dermal-filler category.

Name

Xcelens

Legal name

Xcelens International Sagl

Website

https://xcelens.ch

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1–10 employees

Short description

Xcelens International Sagl is a Swiss manufacturer of hyaluronic-acid-based medical devices and dermo-cosmetics, selling dermal fillers, skin boosters, cosmetic cocktails, and body fillers through a global distributor network to licensed medical aesthetic professionals.

Ownership category

akta.pro rank

Product category

Aesthetic Medical Devices

NAICS

Soap and Cleaning Compound Manufacturing (32561)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

akta.pro secondary industries

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Professional Skincare & Facial Treatments (CRABALAF)

Keywords

• Hyaluronic acid fillers
• Aesthetic medical devices
• Dermal injectables
• Skin boosters
• Dermo cosmetics

Headquarters

HQ city

Chiasso

HQ country

Switzerland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Aesthetic Products (Dermal Fillers, Skin Boosters, Devices): Xcelens generates revenue through the sale of proprietary aesthetic medical devices and dermo-cosmetics, including dermal fillers (Genyal, Xcelens Extra lines), skin boosters (Molecholin, Doublyx Evo, Genyal Genyalift), cosmetic cocktails (Peptidyal, Peptidyak, Anti-Yal), and dermo-cosmetics (Boosterina, UltraHA). Products are sold through a global distributor network to doctors and medical professionals. Revenue is derived from one-time product purchases (medical devices/cosmetics), not subscription-based models.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Xcelens designs, manufactures, and markets hyaluronic acid-based aesthetic medical devices and dermo-cosmetics for medical professionals. Its portfolio spans four categories — Dermal Fillers (Genyal Polyvalent, Genyal Volumae, Xcelens Extra 3/4, Xcelens Extreme HV, Genyal 200 body filler), Skin Boosters (Molecholin, Doublyx Evo, Genyal Genyalift), Cosmetic Cocktails (Peptidyal 86HX, Peptidyal 115, Peptidyak C10, Anti-Yal 1500 hyaluronidase), and Dermo-Cosmetics (Boosterina, UltraHA, Shine C) — sold exclusively through international distributors to licensed doctors and aesthetic practitioners.

Product overview

Xcelens International is a Swiss multinational company that develops and manufactures a comprehensive range of aesthetic medical products organized into four main categories: Dermal Fillers (Genyal and Xcelens Extra lines including Polyvalent, Volumae, Extra 3, Extra 4, Extreme HV, and Genyal 200 for body contouring), Skin Boosters (Molecholin with hyaluronic acid fragments and amino acids, Doublyx Evo with medium molecular weight HA, and Genyal Genyalift for bio-stimulation), Cosmetic Cocktails (Peptidyal 86HX and Peptidyal 115 with multi-weight hyaluronic acid and calcium hydroxyapatite, Peptidyak C10 for acne treatment, and Anti-Yal 1500 hyaluronidase), and Dermo Cosmetics (Boosterina Serum and Cream with PDRN, UltraHA face and eye products with nanopeptides, and Shine C with stabilized Vitamin C). The company focuses on hyaluronic acid-based products manufactured through advanced bio-fermentation and purification processes.

Differentiator

Problem solved

Functional benefit

Brands

• Genyal: Hyaluronic acid dermal fillers and aesthetic products range including Genyal Polyvalent, Genyal Volumae, Genyal Genyalift, and Genyal 200 body filler.
• Xcelens Extra
• Molecholin
• Boosterina
• Doublyx Evo
• Peptidyal
• Peptidyak
• Anti-Yal

Products and services

• Genyal Polyvalent Biphasic dermal filler of non-animal origin using ultra-high molecular weight cross-linked hyaluronic acid (BDDE) indicated for all types of superficial and medium-depth wrinkles, lip contouring, and volume enhancement. Intended for licensed medical professionals administering aesthetic injectable treatments.
• Genyal Volumae Highly cross-linked hyaluronic acid dermal filler offering a balance of high viscosity, elasticity, and long-lasting results of 8 to 18 months for cheeks, nasolabial folds, lip volume, chin, and facial contouring. Intended for licensed medical professionals.
• Genyal Genyalift Skin booster and bio-stimulation product combining 18 mg/ml hyaluronic acid and 20 mg/ml glycerol at ultra-high molecular weight (3 million Daltons) to promote fibroblast proliferation and neo-synthesis of collagen and elastin. For licensed medical professionals performing bio-revitalisation treatments.
• Genyal 200 Implantable medical device body filler based on hyaluronic acid for non-surgical body reshaping of buttocks, calves, depressions, asymmetries, and body profile remodelling. Intended for licensed medical professionals performing body contouring treatments.
• Xcelens Extra 3 Hyaluronic acid dermal filler at 23 mg/ml with 0.3% lidocaine and 3 cross-linked HA chains for treatment of fine lines, perioral wrinkles, crow's feet, glabellar lines, and lip volume and contour. For licensed medical professionals seeking a less painful injection experience.
• Xcelens Extra 4 Hyaluronic acid dermal filler at 23 mg/ml with 0.3% lidocaine and 4 cross-linked HA chains for deep and middle wrinkles, chin, cheeks, jaw contour, and lip volume enhancement. For licensed medical professionals.
• Xcelens Extreme HV High viscosity hyaluronic acid dermal filler at 25 mg/ml with lidocaine for remodelling the lower-third facial contours, chin and jawline projection, and treatment of facial lipoatrophy. For licensed medical professionals.
• Molecholin Innovative intradermal biorivitalising and biostimulating solution based on hyaluronic acid fragments (20–38 monomers), amino acids, and choline that activates fibroblast CD44 receptors for biostimulation and biorevitalisation. Indicated for treatment of wrinkles and skin aging. For licensed medical professionals.
• Doublyx Evo Bio-booster biostimulant based on medium molecular weight hyaluronic acid (1.2 to 1.8 × 10^6 Daltons) produced by Streptococcus equi bacteria, formulated at 20–40 mg/ml concentration for treatment of skin aging. For licensed medical professionals.
• Peptidyal 86HX Exclusive bio-regenerative cosmetic cocktail combining 86 mg/2.6 ml hyaluronic acid at four molecular weights (200k, 400k, 1M, 1.3M Daltons) with amino acids and calcium hydroxyapatite (CaHA), produced without chemical solvents for skin revitalisation. For licensed medical professionals performing mesotherapy and bio-regeneration treatments.
• Peptidyal 115 Bio-restructuring cosmetic cocktail combining hyaluronic acid and amino acids to stimulate fibroblast activity, support collagen, elastin, and HA production, and reduce oxidative stress for skin rejuvenation. For licensed medical professionals performing bio-restructuring treatments.
• Peptidyak C10 Comprehensive synergistic cosmetic cocktail formula for acne-prone skin treatment combining salicylic acid, zinc gluconate, niacinamide, panthenol, hyaluronic acid, and botanical extracts. For licensed medical professionals performing acne treatment protocols.
• Anti-Yal 1500 Hyaluronidase product (1500 IU of dry extract powder per vial, to be mixed with 10 mL of saline solution) for hyaluronic acid filler reversal, adjuvant use in cellulitis treatment, and improved absorption of functional substances. For licensed medical professionals managing filler complications or reversals.
• Boosterina PDRN Filler Serum Light-texture, fast-absorbing dermo-cosmetic serum combining PDRN (Sodium DNA), hyaluronic acid, and glycogen for skin hydration, elasticity, collagen production, scar reduction, and anti-aging treatment of the face, neck, and décolleté. Retail/patient-use dermo-cosmetic from the Boosterina line.
• Boosterina PDRN Anti-Aging & Hydrating Cream Sumptuous emulsion dermo-cosmetic cream with PDRN (Sodium DNA) and hyaluronic acid for intensive anti-aging and moisturising action on the skin. Retail/patient-use dermo-cosmetic from the Boosterina line.
• UltraHA Serum Face Face serum combining ultra-nano sonicated hyaluronic acid with biomimetic nano peptides designed to deliver growth factors for anti-aging treatment. Retail/patient-use dermo-cosmetic from the UltraHA line.
• UltraHA Eyes Eye contour dermo-cosmetic treatment combining ultrasonic hyaluronic acid with specific peptides designed for a Botox-like action on acetylcholine release. Retail/patient-use dermo-cosmetic from the UltraHA line.
• Shine C Serum Facial serum combining ultrasound-fragmented hyaluronic acid with 30% stabilised Vitamin C for brightening, smoothing, anti-aging, moisturising, and antioxidant action. Retail/patient-use dermo-cosmetic from the Shine C line.

Quantifiable outcome

• Genyal Volumae duration: 8-18 months following implantation
• +3 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Galderma: Global leader in aesthetic injectable dermatology with the Restylane and Emervel hyaluronic acid dermal filler ranges serving the same physicians and aesthetic clinics as Xcelens. Direct head-to-head competitor in HA-based facial fillers and skin boosters across overlapping geographies.
• Allergan Aesthetics (AbbVie): Markets the Juvéderm family of HA fillers and SkinMedica dermo-cosmetics, the global volume leader in aesthetic injectables. Directly competes with Xcelens across dermal fillers, skin quality products, and biostimulators, with far larger salesforce and brand reach.
• Merz Aesthetics: German aesthetics specialist behind Belotero Balance, Radiesse (CaHA), and Ultherapy. Competes with Xcelens in HA dermal fillers (Belotero vs. Genyal) and in biostimulation (Radiesse vs. Peptidyal 86HX), targeting the same dermatologist and plastic surgeon accounts.
• Teoxane: Swiss-based HA dermal filler manufacturer (Teosyal range) with proprietary Resilient Hyaluronic Acid technology. Closest geographic and positioning peer to Xcelens — both Geneva-area Swiss firms selling premium HA fillers through international distributors to medical aesthetic professionals.
• IBSA Pharma: Swiss pharmaceutical company with a Profhilo HA-based skin bio-remodelling product and Viscoderm skin booster line. Direct competitor in the skin booster / biorevitalisation category where Xcelens competes with Molecholin, Doublyx Evo and Genyalift.
• Croma-Pharma: Austrian aesthetics manufacturer selling the Princess HA filler range and a complementary skin booster / biorevitalisation portfolio. Comparable to Xcelens in scale, channel model (distributor-led), and product mix spanning dermal fillers, boosters and dermo-cosmetics.
• Laboratoires Vivacy: French manufacturer of the Stylage range of HA dermal fillers with IPN-like cross-linking technology. Comparable mid-sized European aesthetics specialist with a focused injectable portfolio distributed internationally to aesthetic practitioners.

Emerging players

• Sinclair Pharma: UK-based aesthetics company with the MaiLi HA filler line and complementary collagen-stimulator portfolio. Comparable European mid-tier peer competing in the same premium injectable category with similar international distributor GTM.
• SkinTech Pharma Group: European aesthetics company offering chemical peels, mesotherapy cocktails and dermo-cosmetics. Comparable to Xcelens' dermo-cosmetics and cosmetic cocktail lines (Peptidyal, Boosterina) targeting the same medical aesthetic channel with adjacent injectable-adjacent categories.

Regional players

• Hugel (Charmmed): Korean aesthetics manufacturer distributing HA fillers and botulinum toxin across Asia-Pacific. Comparable product technology and end-customers, but primarily competes in APAC rather than Xcelens' European-heavy footprint, serving as a regional benchmark for portfolio breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@XcelensGenyalOfficial
• Facebookfacebook.com/Xcelensofficial
• Instagraminstagram.com/xcelensgenyalofficial
• LinkedInlinkedin.com/company/xcelens-international

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xcelens